Covington Reps Biopharma Co. Landos' $60M Funding Round
Landos Biopharma on Tuesday said investors handed over $60 million in its latest funding round, as the Covington & Burling LLP-guided autoimmune disease treatment developer aims to advance clinical trials for...To view the full article, register now.
Already a subscriber? Click here to view full article